autologous dendritic cell-tumor fusion vaccine

BIOLOGICAL2 trials

Conditions

Adult Diffuse Mixed Cell LymphomaAdult Diffuse Small Cleaved Cell LymphomaAdult Grade III Lymphomatoid GranulomatosisAdult Immunoblastic Large Cell LymphomaAdult Lymphoblastic LymphomaCutaneous B-cell Non-Hodgkin LymphomaExtranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid TissueGrade 1 Follicular Lymphoma

Early Phase 1

Vaccine Therapy With or Without Cryosurgery in Treating Patients With Residual, Relapsed, or Refractory B-Cell Non-Hodgkin Lymphoma

CompletedNCT01239875

Mayo ClinicAdult Diffuse Mixed Cell Lymphoma, Adult Diffuse Small Cleaved Cell Lymphoma, Adult Grade III Lymphomatoid Granulomatosis +13

Start: 2010-11-30End: 2019-07-17Updated: 2020-01-14

Phase 2

Vaccine Therapy in Treating Patients With Stage III or Stage IV Melanoma

NCT00085397

Dana-Farber Cancer InstituteMelanoma (Skin)

Start: 2004-03-31Target: 40Updated: 2009-02-09

Journal for ImmunoTherapy of Cancer2014-11-06

autologous dendritic cell-tumor fusion vaccine

Sponsors

Conditions

Early Phase 1

Phase 2

Related Papers